Zoledronic acid exacerbates inflammation through M1 macrophage polarization
Abstract Background Zoledronic acid (Zol), one of the bisphosphonates, is frequently utilized for the treatment of osteoporosis and bone metastasis. However, the onset of medication-related osteonecrosis of the jaw (MRONJ) following dental treatments has become a serious issue. We reported previousl...
Main Authors: | Junya Kaneko, Toshinori Okinaga, Hisako Hikiji, Wataru Ariyoshi, Daigo Yoshiga, Manabu Habu, Kazuhiro Tominaga, Tatsuji Nishihara |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2018-06-01
|
Series: | Inflammation and Regeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41232-018-0074-9 |
Similar Items
-
Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
by: Fateme Rostami Golmohamdi, et al.
Published: (2016-12-01) -
Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
by: Pieter Ruytinx, et al.
Published: (2018-09-01) -
PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model
by: Yuan Li, et al.
Published: (2018-06-01) -
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial
by: Duneesha de Fonseka, et al.
Published: (2018-08-01) -
A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients – ZAP2
by: Dawn Aitken, et al.
Published: (2018-07-01)